Skip to main content
. 2018 Jul 13;7(7):175. doi: 10.3390/jcm7070175

Figure 1.

Figure 1

APRIL serum concentrations are elevated in patients with pancreatic cancer. (A) Serum concentrations of TWEAK were analyzed by enzyme-linked immunosorbent assay (ELISA) in patients with pancreatic cancer and healthy blood donors as controls; (B) ROC curve analysis comparing the diagnostic value of APRIL and CA19-9 for pancreatic cancer.